期刊
FUTURE ONCOLOGY
卷 16, 期 30, 页码 2445-2455出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2020-0558
关键词
brachytherapy; central nervous system; GammaTile; glioblastoma; radiation therapy; STaRT
类别
Glioblastoma is the most common primary malignant neoplasm of the central nervous system in adults. Standard of care is resection followed by chemo-radiation therapy. Despite this aggressive approach, >80% of glioblastomas recur in proximity to the resection cavity. Brachytherapy is an attractive strategy for improving local control. GammaTile (R) is a newly US FDA-cleared device which incorporates Cs-131 radiation emitting seeds in a resorbable collagen-based carrier tile for surgically targeted radiation therapy to achieve highly conformal radiation at the time of surgery. Embedding encapsulated Cs-131 radiation emitter seeds in collagen-based tiles significantly lowers the technical barriers associated with traditional brachytherapy. In this review, we highlight the potential of surgically targeted radiation therapy and the currently available data for this novel approach.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据